Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
about
Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patientsCoadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic EffectsMolecular control of capillary morphogenesis and maturation by recognition and remodeling of the extracellular matrix: functional roles of endothelial cells and pericytes in health and diseaseErectile dysfunction in heart failure patients: a critical reappraisalHigh glucose-induced increased expression of endothelin-1 in human endothelial cells is mediated by activated CCAAT/enhancer-binding proteinsChromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.Protective effect of α-lipoic acid against antimycin A cytotoxicity in MC3T3-E1 osteoblastic cellsRationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial.Geniposide inhibits high glucose-induced cell adhesion through the NF-kappaB signaling pathway in human umbilical vein endothelial cells.Aminoguanidine inhibits aortic hydrogen peroxide production, VSMC NOX activity and hypercontractility in diabetic mice.Endothelial PGC-1α mediates vascular dysfunction in diabetes.Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunctionInhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic ratsInsulin transcriptionally regulates argininosuccinate synthase to maintain vascular endothelial function.Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism.Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose.Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic PatientsGlycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatmentBiphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.Stem cells in the diabetic infarcted heartCorrection of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model.Automated quantification reveals hyperglycemia inhibits endothelial angiogenic functionTreating coronary disease and the impact of endothelial dysfunction.The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activities of daily living.Chronic Treatment with a Water-Soluble Extract from the Culture Medium of Ganoderma lucidum Mycelia Prevents Apoptosis and Necroptosis in Hypoxia/Ischemia-Induced Injury of Type 2 Diabetic Mouse BrainAssessment of vascular function in individuals with hyperglycemia: a cross-sectional study of glucose - induced changes in digital volume pulse.Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patientsTranscriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.Treadmill running improves hindlimb arteriolar endothelial function in type 1 diabetic mice as visualized by X-ray microangiographyNicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice.The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseasesThe influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities.Clinical and Angiographic Predictors of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction.Simvastatin, atorvastatin, and pravastatin equally improve the hemodynamic status of diabetic rats.Inhibition of ROS-induced apoptosis in endothelial cells by nitrone spin traps via induction of phase II enzymes and suppression of mitochondria-dependent pro-apoptotic signaling.Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.Microvascular Blood Flow Improvement in Hyperglycemic Obese Adult Patients by Hypocaloric Diet.Plantamajoside from Plantago asiatica modulates human umbilical vein endothelial cell dysfunction by glyceraldehyde-induced AGEs via MAPK/NF-κB
P2860
Q24619354-95B10030-9074-4C86-A5A4-172468A2D5F3Q26741423-20217A51-02E2-41ED-83A3-96CB20BA6C55Q26797500-3AFA8A4A-53BB-44A0-8E7B-9F7E67F250F6Q26853624-35D9D944-68C0-4AE0-A746-123CA6CEBE88Q28537960-318E4D5B-8C0F-490B-A239-DDF76CDD847AQ30421709-A6DE4A38-26FC-4BC9-8A76-EA9E56AF520BQ32186920-1C9DD0D9-86AF-42B9-9EE5-5CC072CCB97EQ33556240-D29367E6-01B4-43F5-9DD4-0CFA0AB03F66Q33557886-2230EB29-4635-4EC6-8AF3-8BAB2E2B0AF9Q33611742-AA819B8C-FE2E-4D47-B5A5-4EFF8FC9CC82Q33692952-26ED3CEE-EB1C-44DB-8F39-7784D9BF1A48Q33908252-B7A1E4CA-4EE1-4AA2-A2D8-849C9F13F75CQ34067524-09BFFB52-FD38-4C5B-B8C8-65E37297344AQ34181615-D24034DD-8D64-4A15-BC88-5D3C417A767BQ34229800-37202817-3D8A-48EB-9F49-F099E22B11B2Q34231361-0C770688-B132-4C61-BC38-B6D37711253BQ34442434-EF86DBA8-36BA-44CC-B03D-B908A9CE7881Q34504092-7EC30420-5974-4171-B82A-5FED1AA0C41BQ34517974-1BE1132D-22EC-48C5-8BC9-5E9A896ED3E0Q34620736-9405CBD9-3E16-4C45-AE41-90297F6237A1Q34773408-9CC24B47-D8F2-4984-B4CA-A8B9800EF459Q34983617-721A50F8-E9FA-4C7A-AA35-6919B204ED4AQ35144240-68093244-533B-49CA-AC02-4BF6F8D6EC59Q35196366-003C90E7-2520-4CCB-A38A-6336BB02179FQ35337561-523CBB6F-0D0B-4856-BCF6-E01A34F3EE8DQ35475813-893EBDB2-2A05-40E9-9474-DE50A1E7E884Q35494290-31C58B4B-7771-452E-AF01-4EF9557B2974Q35545754-B53F4896-8E2E-442C-8305-189C481D6394Q35553234-F9E8BB55-E15B-41A1-BF48-3992BC90D598Q35604164-D9D5FDA6-9496-4BF9-8DF0-B9DEEBF8C879Q35642646-1BFF088E-BC41-41CA-BCE2-8AF227FDDB3FQ35825243-EEF63773-03BB-4BD8-87CA-253C10C9C849Q35867073-0F09415A-61FD-44B7-A7BB-4EF021779E1AQ35903671-2BB80EAB-EE73-4A36-9E1B-50CAF8159247Q35971039-A61CFA7F-D4F2-4A53-B1F2-1C5DCD7BCD3AQ35996446-506C80A8-951D-48EC-983F-6FCC57ED6F3AQ36110071-EA5FF71F-D602-4321-85C7-6D797AB5D7A6Q36135105-A45562A9-F0DC-48E3-A68D-C59BAAA4FB04Q36206352-775DB4A2-247D-4369-8D47-9ACA305377DEQ36256454-4B062014-52C9-4F3A-988F-C45A0B2036F2
P2860
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@en
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@nl
type
label
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@en
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@nl
prefLabel
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@en
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.
@nl
P50
P1476
Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets
@en
P2093
Maria Rosaria Carratu'
Sara Gagliardi
P304
P356
10.2174/092986709787002853
P577
2009-01-01T00:00:00Z